한글목차

세계의 인공 생체 활성뼈 시장 규모는 2024년에 10억 6,200만 달러로 평가되었고, 2025-2031년의 예측 기간에 CAGR 6.1%로 확대되어 2031년까지 16억 1,800만 달러로 재조정될 전망입니다.

본 보고서는 인공 생체 활성 뼈의 국경 간 산업 발자국, 자본 배분 패턴, 지역 경제의 상호 의존성, 공급망 재구축에 대한 최근 관세 조정 및 국제적인 전략적 대응책에 대한 종합적인 평가를 제공합니다.

2024년 세계 인공 생체 활성 뼈 생산량은 약 435만 5,000개, 세계 평균 시장 가격은 개당 244달러에 달했습니다.

인공 생체 활성 뼈는 실험실에서 제조된 뼈 유사 물질로, 심한 골절이나 뼈 및 관절 질환으로 인해 손실된 인체 뼈를 대체하는 뼈 이식에 사용됩니다. 인공뼈는 세라믹, 복합재료, 폴리머, 하이드록시아파타이트 등의 재료를 사용하여 제조됩니다. 주로 척추 고정술, 치과 치료, 두개악안면 수술, 관절 재건술, 사지 수술에 사용됩니다.

세계 5대 인공 생체 활성 뼈 제조업체는 Baxter International, Stryker Corporation, Geistlich Pharma, Dentsply Sirona, Medtronic이며, 이들 5개사가 시장의 50% 이상을 점유하고 있습니다. 이 중 Baxter International이 약 17% 시장 점유율로 1위를 차지하고 있습니다. 지역별로는 북미가 가장 큰 시장으로 약 52%, 유럽과 중국이 각각 약 24%, 약 9%의 점유율을 차지하고 있습니다. 제품 유형별로는 세라믹이 전체의 약 78%로 가장 큰 비중을 차지하고 있습니다. 제품 용도별로는 정형외과용이 가장 큰 비중을 차지하고 있으며, 치과용이 그 뒤를 잇고 있습니다.

이 보고서는 인공 생체 활성 뼈 세계 시장에 대해 총 판매량, 매출, 매출액, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추어, 지역/국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목적으로 합니다.

인공 생체 활성 뼈 시장 규모 추정 및 예측은 판매량(천 단위) 및 매출액(백만 달러)으로 제시되며, 2024년을 기준 연도, 2020년에서 2031년까지의 과거 데이터와 예측 데이터를 포함하는 2024년부터 2031년까지의 예측 데이터를 제시합니다. 정량적, 정성적 분석을 통해 독자들이 인공 생체 활성골 관련 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 자사 포지셔닝 분석, 정보에 입각한 비즈니스 의사결정을 할 수 있도록 지원합니다.

시장 세분화

기업별

• Stryker Corporation
• Zimmer Biomet
• Medtronic
• Johnson & Johnson
• Baxter International
• ZimVie
• NuVasive
• Orthofix
• Surgalign
• Globus Medical
• Bioventus
• Geistlich Pharma
• Dentsply Sirona
• Curasan
• Advanced Medical Solutions

유형별 부문

• 세라믹
• 복합재료
• 생체 활성 유리
• 폴리머 및 기타

용도별 부문

• 정형외과
• 치과

지역별

• 북미
  • 미국
  • 캐나다
• 아시아태평양
  • 중국
  • 일본
  • 한국
  • 동남아시아
  • 인도
  • 호주
  • 기타 아시아태평양
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 네덜란드
  • 북유럽 국가
  • 기타 유럽
• 라틴아메리카
  • 멕시코
  • 브라질
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 튀르키예
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동 및 아프리카

영문목차

The global market for Artificial Bioactive Bone was estimated to be worth US$ 1062 million in 2024 and is forecast to a readjusted size of US$ 1618 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Artificial Bioactive Bone cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

In 2024, global Artificial Bioactive Bone production reached approximately 4,355 thousand units, with an average global market price of around US$ 244 per unit.

Artificial bioactive bone is a bone-like material created in laboratory that can be used in bone grafts to replace human bone that was lost due to severe fractures or bone and joint diseases. Artificial bones are made from using materials such as ceramics, composite, polymer, hydroxyapatite, and others. Artificial bones are mostly used for the surgeries of spinal fusion, dental therapies, craniomaxillofacial surgery, joint reconstruction, and extremities.

Global 5 largest manufacturers of Artificial Bioactive Bone are Baxter International, Stryker Corporation, Geistlich Pharma, Dentsply Sirona and Medtronic, which make up over 50%. Among them, Baxter International is the leader with about 17% market share. North America is the largest market, with a share about 52%, followed by Europe and China, with the share about 24% and 9%. In terms of product type, Ceramics occupy the largest share of the total market, about 78%. And in terms of product Application, the largest application is Orthopaedic, followed by Dental.

This report aims to provide a comprehensive presentation of the global market for Artificial Bioactive Bone, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Artificial Bioactive Bone by region & country, by Type, and by Application.

The Artificial Bioactive Bone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Bioactive Bone.

Market Segmentation

By Company

• Stryker Corporation
• Zimmer Biomet
• Medtronic
• Johnson & Johnson
• Baxter International
• ZimVie
• NuVasive
• Orthofix
• Surgalign
• Globus Medical
• Bioventus
• Geistlich Pharma
• Dentsply Sirona
• Curasan
• Advanced Medical Solutions

Segment by Type

• Ceramics
• Composite Material
• Bioactive Glass
• Polymer and Other

Segment by Application

• Orthopaedic
• Dental

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Artificial Bioactive Bone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Artificial Bioactive Bone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Artificial Bioactive Bone in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Artificial Bioactive Bone Product Introduction
• 1.2 Global Artificial Bioactive Bone Market Size Forecast
  • 1.2.1 Global Artificial Bioactive Bone Sales Value (2020-2031)
  • 1.2.2 Global Artificial Bioactive Bone Sales Volume (2020-2031)
  • 1.2.3 Global Artificial Bioactive Bone Sales Price (2020-2031)
• 1.3 Artificial Bioactive Bone Market Trends & Drivers
  • 1.3.1 Artificial Bioactive Bone Industry Trends
  • 1.3.2 Artificial Bioactive Bone Market Drivers & Opportunity
  • 1.3.3 Artificial Bioactive Bone Market Challenges
  • 1.3.4 Artificial Bioactive Bone Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Artificial Bioactive Bone Players Revenue Ranking (2024)
• 2.2 Global Artificial Bioactive Bone Revenue by Company (2020-2025)
• 2.3 Global Artificial Bioactive Bone Players Sales Volume Ranking (2024)
• 2.4 Global Artificial Bioactive Bone Sales Volume by Company Players (2020-2025)
• 2.5 Global Artificial Bioactive Bone Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Artificial Bioactive Bone Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Artificial Bioactive Bone Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Artificial Bioactive Bone
• 2.9 Artificial Bioactive Bone Market Competitive Analysis
  • 2.9.1 Artificial Bioactive Bone Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Artificial Bioactive Bone Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Bioactive Bone as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Ceramics
  • 3.1.2 Composite Material
  • 3.1.3 Bioactive Glass
  • 3.1.4 Polymer and Other
• 3.2 Global Artificial Bioactive Bone Sales Value by Type
  • 3.2.1 Global Artificial Bioactive Bone Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Artificial Bioactive Bone Sales Value, by Type (2020-2031)
  • 3.2.3 Global Artificial Bioactive Bone Sales Value, by Type (%) (2020-2031)
• 3.3 Global Artificial Bioactive Bone Sales Volume by Type
  • 3.3.1 Global Artificial Bioactive Bone Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Artificial Bioactive Bone Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Artificial Bioactive Bone Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Artificial Bioactive Bone Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Orthopaedic
  • 4.1.2 Dental
• 4.2 Global Artificial Bioactive Bone Sales Value by Application
  • 4.2.1 Global Artificial Bioactive Bone Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Artificial Bioactive Bone Sales Value, by Application (2020-2031)
  • 4.2.3 Global Artificial Bioactive Bone Sales Value, by Application (%) (2020-2031)
• 4.3 Global Artificial Bioactive Bone Sales Volume by Application
  • 4.3.1 Global Artificial Bioactive Bone Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Artificial Bioactive Bone Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Artificial Bioactive Bone Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Artificial Bioactive Bone Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Artificial Bioactive Bone Sales Value by Region
  • 5.1.1 Global Artificial Bioactive Bone Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Artificial Bioactive Bone Sales Value by Region (2020-2025)
  • 5.1.3 Global Artificial Bioactive Bone Sales Value by Region (2026-2031)
  • 5.1.4 Global Artificial Bioactive Bone Sales Value by Region (%), (2020-2031)
• 5.2 Global Artificial Bioactive Bone Sales Volume by Region
  • 5.2.1 Global Artificial Bioactive Bone Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Artificial Bioactive Bone Sales Volume by Region (2020-2025)
  • 5.2.3 Global Artificial Bioactive Bone Sales Volume by Region (2026-2031)
  • 5.2.4 Global Artificial Bioactive Bone Sales Volume by Region (%), (2020-2031)
• 5.3 Global Artificial Bioactive Bone Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Artificial Bioactive Bone Sales Value, 2020-2031
  • 5.4.2 North America Artificial Bioactive Bone Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Artificial Bioactive Bone Sales Value, 2020-2031
  • 5.5.2 Europe Artificial Bioactive Bone Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Artificial Bioactive Bone Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Artificial Bioactive Bone Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Artificial Bioactive Bone Sales Value, 2020-2031
  • 5.7.2 South America Artificial Bioactive Bone Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Artificial Bioactive Bone Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Artificial Bioactive Bone Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Artificial Bioactive Bone Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Artificial Bioactive Bone Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Artificial Bioactive Bone Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Artificial Bioactive Bone Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Artificial Bioactive Bone Sales Value, 2020-2031
  • 6.3.2 United States Artificial Bioactive Bone Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Artificial Bioactive Bone Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Artificial Bioactive Bone Sales Value, 2020-2031
  • 6.4.2 Europe Artificial Bioactive Bone Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Artificial Bioactive Bone Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Artificial Bioactive Bone Sales Value, 2020-2031
  • 6.5.2 China Artificial Bioactive Bone Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Artificial Bioactive Bone Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Artificial Bioactive Bone Sales Value, 2020-2031
  • 6.6.2 Japan Artificial Bioactive Bone Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Artificial Bioactive Bone Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Artificial Bioactive Bone Sales Value, 2020-2031
  • 6.7.2 South Korea Artificial Bioactive Bone Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Artificial Bioactive Bone Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Artificial Bioactive Bone Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Artificial Bioactive Bone Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Artificial Bioactive Bone Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Artificial Bioactive Bone Sales Value, 2020-2031
  • 6.9.2 India Artificial Bioactive Bone Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Artificial Bioactive Bone Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Stryker Corporation
  • 7.1.1 Stryker Corporation Company Information
  • 7.1.2 Stryker Corporation Introduction and Business Overview
  • 7.1.3 Stryker Corporation Artificial Bioactive Bone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Stryker Corporation Artificial Bioactive Bone Product Offerings
  • 7.1.5 Stryker Corporation Recent Development
• 7.2 Zimmer Biomet
  • 7.2.1 Zimmer Biomet Company Information
  • 7.2.2 Zimmer Biomet Introduction and Business Overview
  • 7.2.3 Zimmer Biomet Artificial Bioactive Bone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Zimmer Biomet Artificial Bioactive Bone Product Offerings
  • 7.2.5 Zimmer Biomet Recent Development
• 7.3 Medtronic
  • 7.3.1 Medtronic Company Information
  • 7.3.2 Medtronic Introduction and Business Overview
  • 7.3.3 Medtronic Artificial Bioactive Bone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Medtronic Artificial Bioactive Bone Product Offerings
  • 7.3.5 Medtronic Recent Development
• 7.4 Johnson & Johnson
  • 7.4.1 Johnson & Johnson Company Information
  • 7.4.2 Johnson & Johnson Introduction and Business Overview
  • 7.4.3 Johnson & Johnson Artificial Bioactive Bone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Johnson & Johnson Artificial Bioactive Bone Product Offerings
  • 7.4.5 Johnson & Johnson Recent Development
• 7.5 Baxter International
  • 7.5.1 Baxter International Company Information
  • 7.5.2 Baxter International Introduction and Business Overview
  • 7.5.3 Baxter International Artificial Bioactive Bone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Baxter International Artificial Bioactive Bone Product Offerings
  • 7.5.5 Baxter International Recent Development
• 7.6 ZimVie
  • 7.6.1 ZimVie Company Information
  • 7.6.2 ZimVie Introduction and Business Overview
  • 7.6.3 ZimVie Artificial Bioactive Bone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 ZimVie Artificial Bioactive Bone Product Offerings
  • 7.6.5 ZimVie Recent Development
• 7.7 NuVasive
  • 7.7.1 NuVasive Company Information
  • 7.7.2 NuVasive Introduction and Business Overview
  • 7.7.3 NuVasive Artificial Bioactive Bone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 NuVasive Artificial Bioactive Bone Product Offerings
  • 7.7.5 NuVasive Recent Development
• 7.8 Orthofix
  • 7.8.1 Orthofix Company Information
  • 7.8.2 Orthofix Introduction and Business Overview
  • 7.8.3 Orthofix Artificial Bioactive Bone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Orthofix Artificial Bioactive Bone Product Offerings
  • 7.8.5 Orthofix Recent Development
• 7.9 Surgalign
  • 7.9.1 Surgalign Company Information
  • 7.9.2 Surgalign Introduction and Business Overview
  • 7.9.3 Surgalign Artificial Bioactive Bone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Surgalign Artificial Bioactive Bone Product Offerings
  • 7.9.5 Surgalign Recent Development
• 7.10 Globus Medical
  • 7.10.1 Globus Medical Company Information
  • 7.10.2 Globus Medical Introduction and Business Overview
  • 7.10.3 Globus Medical Artificial Bioactive Bone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Globus Medical Artificial Bioactive Bone Product Offerings
  • 7.10.5 Globus Medical Recent Development
• 7.11 Bioventus
  • 7.11.1 Bioventus Company Information
  • 7.11.2 Bioventus Introduction and Business Overview
  • 7.11.3 Bioventus Artificial Bioactive Bone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Bioventus Artificial Bioactive Bone Product Offerings
  • 7.11.5 Bioventus Recent Development
• 7.12 Geistlich Pharma
  • 7.12.1 Geistlich Pharma Company Information
  • 7.12.2 Geistlich Pharma Introduction and Business Overview
  • 7.12.3 Geistlich Pharma Artificial Bioactive Bone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Geistlich Pharma Artificial Bioactive Bone Product Offerings
  • 7.12.5 Geistlich Pharma Recent Development
• 7.13 Dentsply Sirona
  • 7.13.1 Dentsply Sirona Company Information
  • 7.13.2 Dentsply Sirona Introduction and Business Overview
  • 7.13.3 Dentsply Sirona Artificial Bioactive Bone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Dentsply Sirona Artificial Bioactive Bone Product Offerings
  • 7.13.5 Dentsply Sirona Recent Development
• 7.14 Curasan
  • 7.14.1 Curasan Company Information
  • 7.14.2 Curasan Introduction and Business Overview
  • 7.14.3 Curasan Artificial Bioactive Bone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Curasan Artificial Bioactive Bone Product Offerings
  • 7.14.5 Curasan Recent Development
• 7.15 Advanced Medical Solutions
  • 7.15.1 Advanced Medical Solutions Company Information
  • 7.15.2 Advanced Medical Solutions Introduction and Business Overview
  • 7.15.3 Advanced Medical Solutions Artificial Bioactive Bone Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Advanced Medical Solutions Artificial Bioactive Bone Product Offerings
  • 7.15.5 Advanced Medical Solutions Recent Development

8 Industry Chain Analysis

• 8.1 Artificial Bioactive Bone Industrial Chain
• 8.2 Artificial Bioactive Bone Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Artificial Bioactive Bone Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Artificial Bioactive Bone Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer